Jump to content
Advertisement
Sign in to follow this  
Health Reporter

Pubmed-Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.

Recommended Posts

Health Reporter

Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.

Curr Opin Pharmacol. 2019 Jun 04;49:43-51

Authors: Borody TJ, Eslick GD, Clancy RL

Abstract
Fecal microbiota transplantation (FMT) represents the most effective means of therapeutically manipulating the gastrointestinal microbiome. Originally employed as a treatment of last-resort in patients with life-threatening Clostridioides difficile infection (CDI), FMT gained widespread acceptance during the CDI epidemic, where it achieved resolution rates approaching 100%. Following our newfound appreciation for the role of the gut microbiome in both health and disease and owing to FMT's unique mechanism/s of action, FMT is rapidly advancing as an effective treatment for a number of conditions in which the gastrointestinal microbiome is thought to play a role. We review the role of FMT from its beginnings in CDI to its expansion into inflammatory bowel disease, irritable bowel syndrome, and colon cancer.

PMID: 31173991 [PubMed - as supplied by publisher]

View the full article

Share this post


Link to post
Share on other sites
Advertisement
Sign in to follow this  

×
×
  • Create New...